At a glance
- Originator Nucleic Acid Research Institute
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Interferon stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 04 Sep 1998 No-Development-Reported for Viral infections in USA (Unknown route)
- 05 Jan 1996 A preclinical study has been added to the adverse events section (350260
- 19 Dec 1995 Preclinical development for Viral infections in USA (Unknown route)